OS Therapies (OSTX) Change in Cash (2023 - 2026)
OS Therapies' (OSTX) quarterly Change in Cash came in at $647722.0 in Q1 2026, up 125.28% YoY from $287522.8 in Q1 2025, and up 140.31% on a QoQ basis from -$1.6 million in Q4 2025.
OS Therapies (OSTX) Change in Cash (2023 - 2026) Analysis & Trends
OS Therapies (OSTX) has 4 years of Change in Cash data on file, last reported at $647722.0 in Q1 2026.
- Quarterly Change in Cash rose 125.28% year-over-year to $647722.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 171.5% YoY) and the FY2025 annual result came in at -$5.3 million, down 195.78% from the prior year.
- Change in Cash advanced to $647722.0 in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $3.7 million in Q4 2024 to a low of -$2.6 million in Q1 2025.
- A 4-year average of $57467.1 and a median of -$5306.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash jumped 15938.14% — and 2025, when it tumbled 4283.77%.
- Tracing OSTX's Change in Cash over 4 years: stood at $22923.0 in 2023, then jumped by 15938.14% to $3.7 million in 2024, then plunged by 143.71% to -$1.6 million in 2025, then surged by 140.31% to $647722.0 in 2026.
- The last three Change in Cash figures came in at $647722.0 (Q1 2026), -$1.6 million (Q4 2025), and -$925387.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | OS Therapies | 19.46 Mn | 19.46 Mn | - | -712,517.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 647,722.00 |
| Dec 31, 2025 | -1.61 Mn |
| Sep 30, 2025 | -925,387.00 |
| Jun 30, 2025 | -168,994.00 |
| Mar 31, 2025 | -2.56 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | -5,306.00 |
| Mar 31, 2024 | 61,249.00 |
| Dec 31, 2023 | 22,923.00 |
| Sep 30, 2023 | -33,163.00 |
| Jun 30, 2023 | -305,992.00 |
| Mar 31, 2023 | 183,734.00 |